Fraunhofer USA Center for Molecular Biotechnology Begins Clinical Trial of New Malaria Vaccine Approach

01:00 EST 5 Feb 2014 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announced today that clearance was obtained from the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND), Fraunhofer’s plant-derived malaria t...

Other Sources for this Article

Fraunhofer USA Center for Molecular Biotechnology
Dale Ervin, 302-369-3034
dervin@fraunhofer-cmb.org

NEXT ARTICLE

More From BioPortfolio on "Fraunhofer USA Center for Molecular Biotechnology Begins Clinical Trial of New Malaria Vaccine Approach"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story